XIAFLEX Monitoring

7.30.10

7/25/10 SmarTrend.com Earnings Look Ahead: In 12 Days Auxilium

Pharmaceuticals Releases Its Quarterly Numbers
(AUXL)
SmartTrend analysts expect Auxilium Pharmaceuticals
to report a minimal loss of $0.24 shares on sales of $50
million during next week’s Q2 announcement. For the
full year, analysts expect the company to post a loss of
$0.96. In the previous year, the company reported a
loss of $0.32 on sales of $39 million. In the previous
quarter, the company reported a loss of $0.18, topping
consensus estimates for a loss of $0.35. Stock has
fallen 31.6 percent since May of this year.
7/26/10 FOX 11 News (Tucson, Ariz.) Dupuytren’s Contracture Feature
www.Fox11AZ.com Brian Roberts, FOX 11 reporter in Tucson, Ariz.,
features Albert Bueale, the first man in southern
Arizona to receive non-surgical treatment for his
Dupuytren’s contracture disease. Bueale was treated
using XIAFLEX at the University Medical Center’s
Human Motion Institute, an orthopedic clinic in
Tucson.
7/26/10 Peyronie’s Disease Report A Non-surgical solution to Peyronie’s Disease
*also posted on Pat Reynolds of SizeGentics, a company which sells
BreakingNewsHeardNow.com enlargement devices for penises, blogged about
research he conducted on men with Peyronie’s
disease. The device sold is said to correct the penis
curvature by 70 percent and increase size/length by 30
percent. The device is an alternative to surgery and
costs about $400.00.

7/28/10 SmarTrend.com Auxilium Pharmaceuticals (AUXL) Reaches Initial

Support Level, Watch for 1.43% Additional Downside
SmarTrend analysts notice Auxilium shares bearishly
opened below $22.54 on Wednesday and reached the
first support level of $22.12. In the event shares
continue to drop, the next support pivots of $21.79
and $21.04 will be monitored. Also, the shares are
currently trading below the 50-day moving average of
$25.69 and below the 200-day moving average of
$30.71.
7/28/10 MarketWire.com Hand, Wrist and Elbow Specialist of Houston, Dr.
David Hildreth, Now Available at Katy and Sugar Land
to Meet Growing Demand
Houston-based hand, wrist and elbow specialist
expanded office locations and services to the Katy and
Sugarland suburbs. Dr. David Hildreth was the first
 XIAFLEX Monitoring
7.30.10

doctor in the Houston area to use XIAFLEX for

treatment of Dupuytren’s contracture disease.

7/29/10 Benzinga.com SmarTrend's Trend Spotter Sees Continued

Downward Momentum on Shares of Auxilium
Pharmaceuticals (AUXL)
In May, SmarTrend analysts identified a downtrend for
Auxilium Pharmaceuticals (NASDAQ: AUXL) at $32.31.
In approximately 3 months, Auxilium Pharmaceuticals
has returned 31.7% as of Thursday's recent price of
$22.06. Shares are still below the 50-day moving
average of $25.69 and below the 200-moving day
average of $30.71 and analysts expect a continued
decline.
 XIAFLEX Monitoring
7.30.10

July 25. 2010 – SmarTrend.com

Earnings Look Ahead: In 12 days, Auxilium Pharmaceuticals Releases Its Quarterly Numbers (AUXL)

By Chip Brian

Analysts, on average, expect Auxilium Pharmaceuticals (NASDAQ:AUXL) to report a loss of $0.24 on sales
of $50 million on August 05, 2010.

For the full year, analysts expect the company to post a loss of $0.96. In the year-ago period, the
company reported a loss of $0.32 on sales of $39 million.
In the previous quarter, the company reported a loss of $0.18, topping consensus estimates for a loss of
$0.35.

SmarTrend is bearish on shares of Auxilium Pharmaceuticals and our subscribers were alerted to sell on
May 06, 2010 at $32.31. The stock has fallen 31.6% since the alert was issued.
 XIAFLEX Monitoring
7.30.10

July 26, 2010 – FOX 11 News (Tucson, Ariz.)

Dupuytren’s Contracture Feature

By Brian Roberts

Video clip is attached in upfront email.

 XIAFLEX Monitoring
7.30.10

July 26, 2010 – Peyronie’s Disease Report

A Non-Surgical Solution To Peyronie's Disease

By Pat Reynolds

What would you do if you could offer your body a natural new treatment for Peyronie’s without having
to go under the knife? Would you be interested?

Well we have got some great news. At SizeGenetics we can offer you a medically proven traction device
that can correct your curvature by 70%, and at the same time increase your penis size length and girth
by 30% - a double reward.

What is peyronie’s?

Peyronie’s is a build up of fibrous tissues on the tunica albuginea of your penis that hardens into a
plague around the centre of your penis. And the end result? A penile curvature of up to 30% which in
most recorded cases makes sex painful if not impossible to maintain. Yet, this is not the worse of it. If
not treated, peyronies can cause impotency.

There is a solution.

Well, in fact there are many. But take a look at any of these procedures more closely and you’ll see what
we mean when we say each and every one of them comes with its own flaws:

Surgery.

You will need to take time off work, explain to people why you’re going into hospital and then deal with
the side effects off the operation once you finally get out.

With surgery, there is the added risk of causing further deformation to your penis.

Would you believe there are 3 different types? It’s true, and we have to admit they are all fairly
unpleasant.

Plication Procedures

During this procedure surgeons attempt to straighten your penis by trying to shorten the longer side to
the match the one with the curvature.

Yes, simple and effective this procedure does work. But it has got one clear flaw which we think you’ll
agree is a big negative - it essentially shortens your penis when erect.

Not exactly the goal you were searching for. But saying that, there is one possible way to correct it –
using a penis enlargement device.

Once you have recovered from surgery this unique traction device could increase your penis size by 2.75
inches – even longer than it was before! But here in lies the next problem. As well as paying for surgery,
you will also need to buy a device to correct the surgeries mistake… pricey.
 XIAFLEX Monitoring
7.30.10

Especially, when there is a much easier solution.

Excision Grafting Procedures

In this procedure, surgeons incise the lump created through the plaque build up and aim to straighten
your penis through a reconstruction of the resultant defect. How? Using graft material.

Now although this procedure may come with its initial perks, sooner of later these grafts – due to lack of
blood supply – will either begin to contract or cause a deformity.

So despite these initial gains, you are in fact no better off than you were to begin with. And considering
that in many cases this surgery can cause impotency, it is not worth the risk.

Prosthetic Implantation Procedures

Probably the most painful of these 3 surgeries, they involve the placement of hollow (inflatable) or semi-
rigid silastic cylinders into the corpora cavernosa of your penis – Ouch!

And the end result? A straight penis. Great! But the overall pain… is not even worth mentioning.

Now imagine if you could skip all these procedures and offer you body a pain free solution – without the
risk of deformity, without the loss of penis length and without the possibility of impotency.

Well you can.

At SizeGenetics we can understand your hesitation to invest in a device. After all surely surgery is the
best medical path to follow? Well, you’re wrong.

In fact by opting to use surgery you are not only increasing your chances of damaging your penis, but the
pain that will ensue will not be worth it. Not when you can offer your body an affordable non-surgical
method to fix your bent penis.

Using our type 1 medical device, you can confidently wear our traction device for 2-3 hours a day and
experience the permanent results of a 30% penile elongation, plus a 70% correction in your penile
curvature.

Not 1 cm. Not 2 cm. But 2.75 inches.

What’s more our device is so comfortable you won’t even realize that you are wearing it.

For only $389.95 you will receive:

• Medical Type 1 device

• Comfort add-on and spare parts
• PenisHealth DVD and online access
• Real sex for real people online DVD
• Seductive Massage online DVD
 XIAFLEX Monitoring
7.30.10

• Online access to LoveCentria and 54+ DVD’s filled with a variety of tips and sexual positions, that will
have your partner asking for more, more, more

And in just 24 weeks, you could be enjoying the benefits of a bigger, longer penis, and the knowledge
that you attained it all without having to go under the knife.

Order your SizeGenetics device today by clicking here.

 XIAFLEX Monitoring
7.30.10

July 28, 2010 – SmartTrend.com

Auxilium Pharmaceuticals (AUXL) Reaches Initial Support Level, Watch for 1.43% Additional Downside

By Chip Brian

SmarTrend has detected shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) have bearishly opened
below the pivot of $22.54 today and have reached the first level of support of $22.12.
Should the shares continue to fall, we are monitoring the next support pivots of $21.79 and $21.04.
Also, the shares are currently trading below the 50-day moving average of $25.69 and below the 200-
day moving average of $30.71.

SmarTrend, our proprietary pattern recognition system, alerted subscribers to sell shares of Auxilium
Pharmaceuticals on May 06, 2010 at $32.31. Since the call, the stock has fallen 31.6%.
 XIAFLEX Monitoring
7.30.10

July 28, 2010 – MarketWire.com

Hand, Wrist and Elbow Specialist of Houston, Dr. David Hildreth, Now Available at Katy and Sugar
Land to Meet Growing Demand

By Dr. David Hildreth

A growing demand for hand, wrist and elbow specialist Dr. David Hildreth, who once practiced
exclusively at the Texas Medical Center, has prompted the growth of offices in Sugar Land and Katy. The
renowned Houston orthopedic surgeon formerly of Baylor College of Medicine and The Methodist
Hospital System is working to meet growing demand since joining The Richmond Bone & Joint Clinic.
Dr. Hildreth is not only available to patients in Richmond, but also now in Sugar Land and Katy. The
Sugar Land office is located at 15035 SW Freeway, near Williams Trace Blvd., and the Katy office is
located at 21222 Kingsland Blvd.

An original founder of the Tennis Elbow Institute of Houston and among the first Eaton-trained
Dupuytren's physicians in Houston, Dr. Hildreth has served as lead investigator in studies changing the
treatment options available for many common hand, wrist and elbow conditions.

A published author who served as an associate professor at The Methodist Hospital System and Weill
Medical College of Cornell University, Dr. Hildreth stays ahead of "standard of care" to bring his patients
such advanced treatment options as Needle Aponeurotomy (NA) and non surgical XIAFLEX® injection
therapy in the treatment of Dupuytren's Contracture, as well as less invasive treatment for carpal and
cubital tunnel syndromes, sports injuries and degenerative joint conditions.

"Practicing at a specialized orthopedic clinic such as RBJC, we have the advantage of offering the latest
treatment options far more rapidly. We devote a tremendous amount of time studying the new
techniques and technology within the industry to remain ahead of current 'standards,'" said Hildreth.
"These new offices are a response to patients wanting personalized care and easier access to a higher
quality of medical services in their neighborhood. We're pleased to be able to provide them with this
increased accessibility," added Hildreth.

Featured in "Medical Advances" of Newsweek magazine and named for the fifth consecutive year
among the Texas Monthly list of Super Doctors and H Texas magazine's Top Docs, view a video of Dr.
Hildreth and his staff as they provide personalized treatment and rehabilitation programs for hand, wrist
and elbow patients.

For more information, please contact:

Dr. David Hildreth
(877) 702-MYMD
www.davidhildrethmd.com
 XIAFLEX Monitoring
7.30.10

July 29, 2010 – Benzinga.com

SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of Auxilium
Pharmaceuticals (AUXL)

By Chip Brian

SmarTrend identified a Downtrend for Auxilium Pharmaceuticals (NASDAQ: AUXL) on May 06, 2010 at
$32.31. In approximately 3 months, Auxilium Pharmaceuticals has returned 31.7% as of today's recent
price of $22.06.

Auxilium Pharmaceuticals is currently below its 50-day moving average of $25.69 and below its 200-day
moving average of $30.71. Look for these moving averages to decline to confirm the company's
downward momentum.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for
any changes in momentum for shares of Auxilium Pharmaceuticals.